Renal graft loss with plasma cell‐rich acute rejection in cadaveric renal transplantation: a case report
- 14 June 2005
- journal article
- case report
- Published by Wiley in Clinical Transplantation
- Vol. 19 (s14) , 71-75
- https://doi.org/10.1111/j.1399-0012.2005.00394.x
Abstract
Abstract: We reported a case of renal graft loss in cadaveric renal transplantation. An episode biopsy with renal dysfunction showed plasma cell predominant inflammatory infiltration in the interstitium without a finding of vascular or glomerular rejection, and was diagnosed as plasma cell‐rich acute rejection (PCAR). Despite intensive immunosuppressive therapy, the renal histology of repeated biopsies showed persistent plasma cell infiltration and the graft was finally lost. Immunohistological staining and immunoglobulin gene rearrangement studies to estimate the clonality of inflammatory cells revealed that the infiltrating plasma cells were polyclonal in origin. Epstein–Barr virus was not detected by in situ hybridization. From these results, we excluded the possibility of post‐transplant lymphoproliferative disorder (PTLD); however, a precise definition and differential diagnosis between PCAR and PTLD has not yet been fully determined. As therapeutic regimens for PCAR and PTLD are different, definite guidelines for diagnosis and treatments of PCAR need to be established.Keywords
This publication has 5 references indexed in Scilit:
- A case of plasmacytic hyperplasia arising in a kidney allograft salvaged with immunosuppression reduction aloneClinical Transplantation, 2004
- Humanized anti‐CD20 monoclonal antibody (Rituximab) treatment for post‐transplant lymphoproliferative disorder*Clinical Transplantation, 2003
- The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsiesHuman Pathology, 2001
- PLASMA CELL-RICH ACUTE RENAL ALLOGRAFT REJECTION1Transplantation, 1999
- Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disordersBlood, 1995